Michael D. Dalzell/Editing Samples



This hybrid magazine/journal has a split readership — third-party payers, employers, and policy makers. Each group has its own agenda and varying levels of understanding of biologics. From 2004 to 2010, as the editor of Biotechnology Healthcare, I broke down complex concepts into useful articles for all readers.